Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe.
Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections.
Debiopharm completed the development and has licensed out 2 compounds: - Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur® 1, 3 and 6-month formulation and Moapar®/Salcacyl® -Oxaliplatin, the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat®
If your university or biotech start-up has interesting molecules in early-stage research and you’re seeking a competent and committed partner to develop them further, please contact us!
Company Details
- Employees
- 476
- Founded
- -
- Address
- Chemin Messidor 5-7, Lausanne,1006,switzerland
- Phone
- 41213210111
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- debiopharm.com
- Keywords
- drug development, digital health, oncology, antimicrobials, Healthcare, Biopharmaceutical, drug delivery, Science and innovation, Radioligand Therapy, Antibody Drug Conjugates, DNA Damage Response Inhibition.
- HQ
- Lausanne
Debiopharm Questions
Debiopharm's helpline number is 41213210111
Debiopharm's website is debiopharm.com
Debiopharm's LinkedIn profile is https://ch.linkedin.com/company/debiopharminternational
Debiopharm has
476 employees.
View email and phone details for 476
employees at Debiopharm.
Debiopharm's industry is
Pharmaceutical Manufacturing
Debiopharm's top competitors are
Siegfried,
Biogen,
Celonic Group,
Sophia Genetics,
Takeda,
Idorsia Pharmaceuticals Ltd,
Sobi - Swedish Orphan Biovitrum Ab (Publ),
Lonza,
Ypsomed Ag,
Ac Immune.
Debiopharm's categories are Pharmaceutical Manufacturing
Debiopharm's founding year is 1979
